4521: 科研製薬 | 貸借残高(日証協公表)

報告日貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比新規貸付成約高前週比新規借入成約高(自己)前週比新規借入成約高(転貸)前週比
2025-01-10(金)442,143+1,59022,835+1,300460,242+21,299179,173+96,392500+50089,306+69,906
2024-12-30(月)440,553-17,39521,535-400438,943+7,20082,781-424,2550019,400-33,800
2024-12-27(金)457,948+37,50021,935+400431,743+26,400507,036+238,2640053,200-90,801
2024-12-20(金)420,448+206,67521,535-5,700405,343+122,900268,772-70,70700144,001+70,560
2024-12-13(金)213,773-11327,235-1,500282,443+78,391339,479+224,7170-4,50073,441-781
2024-12-06(金)213,886-25,80028,735+3,900204,052+29,360114,762+22,5764,500+4,50074,222+60,622
2024-11-29(金)239,686-13,83524,835-1,300174,692-38,73692,186-85,5310013,600-24,900
2024-11-22(金)253,521-63,54826,135-100213,428-10,902177,717-202,6380-10038,500-92,903
2024-11-15(金)317,069+15,11226,2350224,330+10,293380,355-14,018100+29131,403+122,303
2024-11-08(金)301,957+12,50026,235-300214,037-2,600394,373+133,98271-6,1189,100-29,608
2024-11-01(金)289,457-26,87626,535+21,300216,637-25,020260,391-235,0696,189+5,04238,708+10,808
2024-10-25(金)316,333-21,1475,235-19,200241,657-3,689495,460+161,3001,147+1,14727,900+20,102
2024-10-18(金)337,480+16,90024,435-15,193245,346-19,399334,160+12,2920-3,3007,798-26,346
2024-10-11(金)320,580+39,90039,628-2,400264,745+8,223321,868+13,4303,300+3,30034,144-19,554
2024-10-04(金)280,680+73,67042,028-105,778256,522+19,501308,438+45,8550-49053,698-29,518
2024-09-27(金)207,010-95,681147,806-1,529237,021-76,624262,583+62,607490-36,66383,216+54,930
2024-09-20(金)302,691+3,776149,335+113,188313,645+31,395199,976-91,94137,153-39,11228,286+11,343
2024-09-13(金)298,915-42,54836,147-13,800282,250-50,960291,917-23,82076,265+76,26516,943-91,843
2024-09-06(金)341,463-3,25249,947-2,500333,210+4,800315,737+94,8910-200108,786+35,265
2024-08-30(金)344,715-95,01752,447-200328,410-24,601220,846-203,918200+18373,521+118